Restoration of defective cross-presentation in tumors by gemcitabine

Tumor antigen cross-presentation by dendritic cells (DCs) to specific CD8(+) T cells is central to antitumor immunity. Although highly efficient in draining lymph nodes, it is defective within the tumor site itself. Importantly, an immunogenic chemotherapy, gemcitabine, reverses this defect, allowin...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncoimmunology
Main Authors: McDonnell, Alison M, Joost Lesterhuis, W, Khong, Andrea, Nowak, Anna K, Lake, Richard A, Currie, Andrew J, Robinson, Bruce WS
Formato: Artigo
Idioma:Inglês
Publicado em: Taylor & Francis 2015
Assuntos:
Author's View
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4485774/
https://ncbi.nlm.nih.gov/pubmed/26155402
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2015.1005501
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados